The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report - Replacement

17 Sep 2020 12:43

RNS Number : 3315Z
Location Sciences Group PLC
17 September 2020
 

The following amendment has been made to the 'Half-year Report' announcement released on 15 September 2020 at 07:00 under RNS No 9512Y.

The text in the Outlook section of the Chairman's Report has been corrected to "…cash runway has been maintained to Q2 2021,…" instead of Q2 2020 as previously stated.

All other details remain unchanged.

The full amended text is shown below.

 

Location Sciences Group PLC

("Location Sciences" or the "Company")

Half Year Results

 

 

Location Sciences Group PLC, (AIM: LSAI), the leading location verification company, is pleased to announce its unaudited interim results for the six months ended 30 June 2020.

 

Highlights

 

· Revenue increased 43% to £650,385 (H1 2019: £454,872)

· Verify revenues increased 39% to £157,526 (H1 2019: £113,536)

· Administrative expenses reduced by 35% to £785,066 (H1 2019: £1,204,558)

· EBITDA loss reduced by 63% to £334,630 (H1 2019: £908,970)

· Cash reserves £1,652,969 as at 30 June 2020 (31 December 2019: £1,493,904)

 

The Company's partnership with X-Mode saw an additional £190,713 of securitised Insights revenues recognised in H1 2020, which represents revenues payable by X-Mode in the period from 1 July 2020 to 31 December 2021. These revenues have enhanced H1 2020's performance accordingly. Excluding the X-Mode securitisation revenues referred to above, revenues for the six months ended 30 June 2020 were £459,672, being marginally ahead of the £454,872 in H1 2019 and the EBITDA loss was £525,343, representing a like-for-like decrease of 42% compared to the EBITDA loss of £908,970 in H1 2019.

 

As previously reported, our Verify revenues - which rely on location advertising - were down significantly in comparison to management's expectations in the first half of the year. While the outlook remains uncertain, July and August saw Verify revenues on an upward trajectory as more location-based advertising campaigns resumed. The management team is encouraged by recent take up for Verify Proximity by Aldi in the UK as well as ongoing trials with some major brands in the US. The focus is now on turning these trials into contracts.

 

This aligns with the Board's view that brands and agencies are shifting their approach to targeting local markets (to match post-pandemic consumer behaviour) and to brand safe campaigns which both maintain brand image and enhance performance.

 

Group M's (the world's largest advertising agency) announcement in July 2020 that location verification is part of the brand safety guidelines is a good indicator of this.

 

The most significant news in the first half of 2020 was the successful launch of Verify Audience in the US, which went live in June 2020. Verify Audience is the first independent product available in the digital advertising market which measures the quality of the inventory being used for location-based marketing. As previously announced, InMarket was the first contract win for Verify Audience and they have since acquired assets from NinthDecimal elevating them to become a leader in the US location-based marketing industry. We are very much looking forward to working with them and, with several tests underway with other brands, agencies, and suppliers, the team is confident of securing further contract wins over the coming months.

 

Commenting on the results, Mark Slade, Chief Executive of Location Sciences, said:

 

"Although COVID has impacted our short-term revenues from Verify, I'm encouraged by the medium-term strategic partnerships we are working on with key agencies and suppliers, particularly in the US. Launching our audience verification platform in the US following successful trials, has been a critical milestone for the business and we are optimistic this will start to have a meaningful impact on revenues in the final quarter of the year. We hope shareholders can appreciate the work going on behind the scenes to build momentum and keep costs as low as possible. As part of our drive to improve shareholder communications, we will also be increasing our social media presence and welcome shareholders to follow our progress and activity on Linkedin and Twitter."

 

A copy of this announcement and the Company's interim report are available on the Company's website www.locationsciencesgroup.ai

 

 

For further information please contact:

 

Location Sciences Group PLC

via Milk & Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, CFO and Commercial Director

 

 

 

Shore Capital (Nominated Adviser and Joint Broker)

Tel: +44 (0)20 7408 4090

 

Tom Griffiths/David Coaten

 

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

Milk & Honey PR

Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

 

About Location Sciences Group PLC:

 

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

Rule 26 website: www.locationsciencesgroup.ai

Verify website: www.locationsciences.ai

LinkedIn: https://www.linkedin.com/company/locationsciences

Twitter: @LocationSci

 

 

 

CHAIRMAN'S REPORT FOR THE PERIOD ENDED 30 JUNE 2020

 

Introduction

 

This has been a challenging period for Location Sciences, as it has been for many businesses globally. I am proud of the way that the team has responded to the COVID-19 pandemic, focusing on revenue growth areas and helping to reduce costs where possible to mitigate the virus' impact on the Company's operational and financial performance.

 

Pleasingly, Insight product revenues in the period have marginally outperformed management's expectations. This is due to new contracts being secured to analyse the impact of COVID-19 on people's movement across the UK. These contract wins, which should continue for the foreseeable future, have outweighed some contract losses with customers who have been hard hit by the pandemic.

 

Frustratingly the management team spent a lot of time and resources in contacting the relevant UK Government departments in respect to both track and trace and the use of location data to track movements to inform government decisions. These efforts unfortunately led to no material interest.

 

As previously reported, our Verify revenues - which rely on location advertising - were down significantly in comparison to management's expectations in the first half of the year. While the outlook remains uncertain, July and August saw Verify revenues on an upward trajectory as more location-based advertising campaigns resumed. The management team is encouraged by recent take up for Verify Proximity by Aldi in the UK as well as ongoing trials with some major brands in the US. The focus is now on turning these trials into contracts.

 

This aligns with the Board's view that brands and agencies are shifting their approach to targeting local markets (to match post-pandemic consumer behaviour) and to brand safe campaigns which both maintain brand image and enhance performance.

 

Group M's (the world's largest advertising agency) announcement in July 2020 that location verification is part of the brand safety guidelines is a good indicator of this. The team are in active communications with the Group M team to help support this initiative.

 

The most significant news in the first half of 2020 was the successful launch of Verify Audience in the US, which went live in June 2020. Verify Audience is the first independent product available in the digital advertising market which measures the quality of the inventory being used for location-based marketing. As previously announced, InMarket was the first contract win for Verify Audience and they have since acquired assets from NinthDecimal elevating them to become a leader in the US location-based marketing industry. We are very much looking forward to working with them and, with several tests underway with other brands, agencies, and suppliers, the team is confident of securing further contract wins over the coming months.

 

Trading performance

 

Unaudited underlying revenues (excluding X-Mode securitisation) for the six months ended 30 June 2020 were

£459,672. This was marginally ahead of the £454,872 revenues in H1 2019 despite the impact of COVID-19. Total reported revenues (including X-Mode securitisation) were £650,385 being an increase of 43% compared with H1 2019.

 

Verify revenues were adversely impacted by significantly reduced advertising spend in Q2 2020. This led to Verify delivering disappointing revenues of £157,526 albeit still 39% ahead of the £113,536 delivered in H1 2019.

 

The Company's partnership with X-Mode saw an additional £190,713 of securitised Insights revenues recognised in H1 2020, which represents revenues payable by X-Mode in the period from 1 July 2020 to 31 December 2021. Excluding these revenues, the underlying performance of the Insights business saw £302,146 of revenues, which is an 11% reduction on the £341,336 delivered in H1 2019. This is ahead of the original management expectations, which were lower than the previous period in 2019, due to the sale of the customer contracts as part of the X-Mode partnership which also saw costs being removed from the Company.

 

To mitigate the impact of the pandemic, the Company's directors implemented a cost reduction programme. The team is pleased to report that administrative expenses have been significantly reduced in the period to £785,066. This compares with £1,204,558 in H1 2019 (a reduction of 35%).

 

The combination of the impact of the X-Mode partnership and the cost reductions implemented by the Board has led to a much-improved EBITDA loss of £334,630 in the period. Excluding the securitisation of X-Mode revenues the comparative EBITDA loss was £525,343, representing a like for like decrease of 42% compared to 2019 (H1 2019: EBITDA loss £908,970).

 

The gross margin in the period of 66% was in line with management's expectations. This was again impacted by the X-Mode partnership and compares favourably to the 59% reported for H1 2019. Verify remains a higher gross margin business than Insights and the gross margin is expected to improve as the sales mix shifts towards Verify in H2 2020.

 

Cash resources

 

In March 2020, the Company raised approximately £0.975 million (before expenses) through an equity placing, which comprised the issue and allotment of 111,430,000 new ordinary shares and an additional approximately

£0.07 million was raised through the issue and allotment of 74,057,996 new ordinary shares pursuant to the issue of warrants.

 

The combination of the £1.05 million of capital raised, together with the 35% reduction in administration expenses, resulted in the Company having cash reserves of £1,652,969 at 30 June 2020 (31 December 2019: £1,493,904). Furthermore, I can report that as of 31 August 2020 the Company's cash reserves were approximately £1.4 million, which the Board believes should be sufficient for the Company's requirements into Q2 2021.

 

Importantly, the Company continued investing into its products during the period, with approximately £0.22 million of this investment capitalised in H1 2020, compared with £0.15 million in H1 2019.

 

Swift action taken to mitigate the impact of Covid-19

 

It has been a challenging time for location-based advertising - particularly within sectors that rely on people's movement, such as retail and QSR. In the last few months, however, with strict lockdowns being eased in the UK and the US, the Company has seen signs that advertisers are beginning to spend again. While the levels of spend are unlikely to reach 2019 levels, the Board expects the focus on local advertising to be a positive driver for the Company's media verification revenues in H2 2020 and particularly in Q4 when the majority of the Company's Verify revenues should be secured.

 

While Verify revenues were negatively impacted, the team worked hard to replace these revenues. The Company won a number of new Insights contracts predominantly for COVID-19 data analysis. This only had a modest impact on H1 2020 with the main benefits of these contract wins to be seen in H2 2020. The performance of the Insights business was buoyed in H1 2020 with the securitisation of the X-Mode partnership revenues, allowing the Company to report £492,859 Insight revenues for H1 2020 compared to £341,336 for H1 2019.

 

The Board also made swift cost reductions to mitigate the impact of the downturn in revenues. These included salary reductions for the Board and senior members of the team, a hiring freeze and staff being furloughed. In addition, with the exception of product development, all operational expenses were reduced to the minimal viable levels during April, May and June 2020 when the UK and US saw their strictest lockdown measures being implemented. As reported above, these actions offset the impact of the lower revenues on the cash runway of the business.

 

Verify progress

 

As announced in its COVID-19 update on 23 March 2020, the Company launched an updated version of its Verify Proximity platform at the end of April 2020. This gives its customers a clearer picture of how to obtain better value from their location spend and how to drive better performance. New potential clients began testing the Verify Proximity platform in H2 and the Board expects further progress in the coming months as advertisers begin to promote their products and services again.

 

In June 2020, Location Sciences launched its Verify Audience product in the US. Verify Audience allows brands, agencies and suppliers to check the validity of location based derived audience segments. It also enables a review of historical movements in contrast to proximity which validates the real time locations as digital advertising campaigns are delivered. It is worth noting that the audience verification platform requires significant operational set up for both the agencies and suppliers and, therefore, will take time to scale. The management team are however confident that once established into workflows the product and service will be extremely sticky and has potential to outstrip media verification revenues.

 

As previously announced, Verify Audience has already secured its first customer win, InMarket, a leader in 360-degree consumer intelligence in the US. It was pleasing to secure the partnership with InMarket so soon after launch which, importantly, shows how the Company is broadening the appeal of its Verify product suite to agencies, brands and suppliers. InMarket's recent acquisition of assets from NinthDecimal broadens the scope of this opportunity further for the Company.

 

iOS 14 - Changing the Location Landscape

 

Apple's latest iOS update (iOS 14) is now due to be released in October 2020 and will see users being given the choice of sharing an approximate location as an alternative to their precise location or no location at all. The announced change to the IDFA (the unique identifier for advertisers), whereby the choice to share the IDFA will be elevated to a per App setting in contrast to a system wide setting (where it currently resides), has been delayed until early 2021 to give advertisers time to adapt.

 

This new operating system update will add greater consumer choice and transparency features that will have a significant impact on location advertisers - particularly when it comes to behavioural audiences and precise location targeting at scale.

 

The Board expects that these changes will be welcomed by consumers which will, as a result, increase the volume of location data being shared - albeit the increase in volume is likely to be driven by the sharing of approximate location (rather than not sharing at all). This should provide further positive momentum to the growth of Verify.

 

Outlook

 

Whilst the future remains uncertain, the action the Company has taken to manage and mitigate the impact of COVID-19 has provided the opportunity to continue to invest in our Verify product suite. Our objective continues to be to become the default location verification company for the $160 billion global mobile advertising industry.

 

The promising reception of Verify Audience from potential customers is encouraging, with further contract wins likely in H2 2020. The Company is also targeting further contract wins for Verify Proximity in the coming months with the aim of delivering significant year on year growth for Verify in 2020.

 

While the cash runway has been maintained to Q2 2021, it is worth noting that further funds will be required to bring the Company to positive cash flow generation. The Board will explore all available options in due course with the objective to optimise shareholder value prior to deciding on a particular funding route.

 

I would like to thank the team for their commitment and resilience and all shareholders for their continued support during these unprecedented times.

 

Kelvin Harrison Chairman

 

 

LOCATION SCIENCES GROUP PLC

CONSOLIDATED PROFIT AND LOSS ACCOUNT FOR THE PERIOD ENDED 30 JUNE 2020

 

 

Six months

ended

 

Six months

ended

 

 

 

Year ended

30 June

 

30 June

 

 

31 December

2020

 

2019

 

 

2019

Unaudited

 

Unaudited

 

 

Audited

 

Note

£

 

£

 

 

£

Revenue

4

650,385

 

454,872

 

 

1,206,254

Cost of sales

 

(219,287)

 

(187,728)

 

 

(398,753)

Gross profit

 

431,098

 

267,144

 

 

807,501

Grant income

 

10,000

 

28,000

 

 

25,280

Other income

 

9,338

 

250

 

 

-

Administrative expenses

 

(785,066)

 

(1,204,558)

 

 

(2,545,767)

Amortisation and depreciation

 

(301,807)

 

(232,925)

 

 

(558,256)

Operating loss

4

(636,437)

 

(1,142,089)

 

 

(2,271,242)

Finance income

 

95

 

112

 

 

229

Finance expense

 

(2,810)

 

-

 

 

(12,707)

Loss before tax

 

(639,152)

 

(1,141,977)

 

 

(2,283,720)

Taxation

 

60,000

 

92,474

 

 

166,908

Loss for the financial year attributable to owners of the company

 

 

 (579,152)

 

 

 (1,049,503)

 

 

 

 (2,116,812)

Earnings per share

 

 

 

 

 

 

 

Loss per share - basic and diluted

 

(0.12p)

 

(0.31p)

 

 

(0.61p)

 

The above results were derived from continuing operations.

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE YEAR ENDED 30JUNE 2020

 

 

 

 

Six months

 

Six months

 

 

 

ended

 

ended

 

Year ended

 

30 June

 

30 June

 

31 December

 

2019

 

2019

 

2019

 

Unaudited

 

Unaudited

 

Audited

 

£

 

£

 

£

Loss for the year

(579,152)

 

(1,049,503)

 

(2,116,812)

Foreign currency translation gains/(losses)

(7,006)

 

-

 

(3,370)

Total comprehensive income for the year attributable to owners of the company

 

 (586,158)

 

 

 (1,049,503)

 

 

 (2,120,182)

 

 

CONSOLIDATED BALANCE SHEET AS AT 30 JUNE 2020

 

 

 

30 June

2020

Unaudited

 

30 June

2019

Unaudited

 

31 December

Audited

2019

Note

£

 

£

 

£

Non-current assets

 

 

 

 

 

 

Intangible assets

 

1,156,227

 

1,251,119

 

1,185,237

Property, plant and equipment

 

56,668

 

17,422

 

106,864

 

 

1,212,895

 

1,268,541

 

1,292,101

Current assets

 

 

 

 

 

 

Trade and other receivables

 

556,769

 

436,746

 

407,321

Current tax asset

 

60,000

 

328,197

 

166,909

Cash and cash equivalents

 

1,652,969

 

1,493,904

 

1,325,739

 

 

2,269,738

 

2,258,847

 

1,899,969

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

(234,388)

 

(297,250)

 

(349,079)

Current portion of borrowings

 

(24,118)

 

(152)

 

(74,918)

 

 

(258,506)

 

(297,402)

 

(423,997)

Net current assets

 

2,011,232

 

1,961,445

 

1,475,972

Net assets

 

 3,224,127

 

 3,229,986

 

 2,768,073

Capital and reserves

 

 

 

 

 

 

Called up share capital

5

14,263,288

 

13,735,564

 

14,008,033

Share premium reserve

 

19,250,749

 

18,214,502

 

18,508,593

Merger relief reserve

 

11,605,556

 

11,605,556

 

11,605,556

Capital reserve

 

209,791

 

209,791

 

209,791

Other reserves

 

(9,204,463)

 

(9,225,108)

 

(9,225,108)

Retained earnings

 

(32,900,794)

 

(31,310,319)

 

(32,338,792)

Total equity

 

 3,224,127

 

 3,229,986

 

 2,768,073

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED 30 JUNE 2020 EQUITY ATTRIBUTABLE TO THE PARENT COMPANY

 

 

 

Share capital

 

Share

premium

 

Merger relief

reserve

 

 

Capital reserve

 

 

Other reserves

 

Retained

earnings

 

 

Total

£

 

£

 

£

 

£

 

£

 

£

 

£

At 1 January 2019

13,713,498

 

18,168,965

 

11,605,556

 

209,791

 

(9,225,108)

 

(30,284,972)

 

4,187,730

Loss for the period

-

 

-

 

-

 

-

 

-

 

(1,049,503)

 

(1,049,503)

Issues of shares

22,066

 

45,537

 

-

 

-

 

-

 

-

 

67,603

Share based transfer

-

 

-

 

-

 

-

 

-

 

24,156

 

24,156

At 30 June 2019

 13,735,564

 

18,214,502

 

 11,605,556

 

 209,791

 

(9,225,108)

 

(31,310,319)

 

3,229,986

 

At 1 January 2019

 

13,713,498

 

 

18,168,965

 

 

11,605,556

 

 

209,791

 

 

(9,225,108)

 

 

(30,284,972)

 

 

4,187,730

Loss in year

-

 

-

 

-

 

-

 

-

 

(2,116,812)

 

(2,116,812)

Other Comprehensive Income

-

 

-

 

-

 

-

 

-

 

(3,370)

 

(3,370)

Issues of shares

294,535

 

339,628

 

-

 

-

 

-

 

-

 

634,163

Share based payments

-

 

-

 

-

 

-

 

-

 

48,036

 

48,036

Transition adjustment upon application of IFRS 16

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

18,326

 

 

18,326

At 31 December 2019

14,008,033

 

18,508,593

 

11,605,556

 

209,791

 

(9,225,108)

 

(32,338,792)

 

2,768,073

 

At 1 January 2020

 

14,008,033

 

 

18,508,593

 

 

11,605,556

 

 

209,791

 

 

(9,225,108)

 

 

(32,338,792)

 

 

2,768,073

Loss for the period

-

 

-

 

-

 

-

 

-

 

(579,152)

 

(579,152)

Other comprehensive income

-

 

-

 

-

 

-

 

-

 

(7,006)

 

(7,006)

Issue of shares

255,255

 

742,156

 

-

 

-

 

-

 

-

 

997,411

Share based payments

-

 

-

 

-

 

-

 

-

 

24,156

 

24,156

Shares to be issued

-

 

-

 

-

 

-

 

20,645

 

-

 

20,645

At 30 June 2020

 14,263,288

 

19,250,749

 

11,605,556

 

209,791

 

  (9,204,463)

 

(32,900,794)

 

3,224,127

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 30 JUNE 2020

 

 

Six months

ended

 

Six months

ended

 

 

Year ended

30 June

 

30 June

 

31 December

 

 

 

 

2020

Unaudited

£

 

2019

Unaudited

£

 

2019

Audited

£

Cash flows from operating activities

 

 

 

 

 

 

Loss for the year

 

(579,152)

 

(1,049,503)

 

(2,116,812)

Adjustments to cash flows from non-cash items

 

 

 

 

 

 

Depreciation and amortisation

 

301,807

 

232,895

 

558,256

Foreign exchange (gains) / losses

 

(7,006)

 

(7,056)

 

(3,370)

Finance income

 

(95)

 

(112)

 

(229)

Finance costs

 

2,810

 

-

 

12,707

Share based payment transactions

 

24,156

 

91,759

 

48,036

Income tax expense

 

(60,000)

 

(92,474)

 

(166,908)

Shares issued other than for cash

 

97,568

 

-

 

67,604

 

 

(219,912)

 

(824,491)

 

(1,600,716)

Working capital adjustments

 

 

 

 

 

 

Increase in trade debtors

 

(149,448)

 

(70,426)

 

(48,057)

Decrease in trade creditors

 

(114,691)

 

(73,124)

 

(21,294)

Cash used in operations

 

(484,051)

 

(968,041)

 

(1,670,067)

Income taxes received

 

166,909

 

-

 

235,722

Net cash used in operating activities

 

(317,142)

 

(968,041)

 

(1,434,345)

Cash flows from investing activities

 

 

 

 

 

 

Interest received

 

95

 

112

 

229

Acquisitions of tangible assets

 

(1,277)

 

(8,371)

 

(8,371)

Acquisition of intangible assets

 

(221,324)

 

(145,251)

 

(306,415)

Net cash used in investing activities

 

(222,506)

 

(153,510)

 

(314,557)

Cash flows from financing activities

 

 

 

 

 

 

Proceeds from issue of ordinary shares, net of issue costs

 

 

920,488

 

 

-

 

 

566,558

Payments to finance lease creditors

 

-

 

-

 

(152)

IFRS 16 liability repayment

 

(53,610)

 

-

 

(107,220)

Net cash generated from financing activities

 

866,878

 

-

 

459,186

Net increase/(decrease) in cash and cash equivalents

 

 

327,230

 

 

(1,121,551)

 

 

(1,289,716)

Cash and cash equivalents at beginning of period

 

 

1,325,739

 

 

2,615,455

 

 

2,615,455

Cash and cash equivalents at end of period

 

1,652,969

 

1,493,904

 

1,325,739

 

 

NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2020

 

1 General information

Location Sciences Group PLC and its subsidiaries Location Sciences AI Limited and Location Sciences (US), Inc. (together the "Group") specialise in providing two core solutions to its customers, namely: 1) Location data and insights - this is a SaaS where customers query Location Sciences' UK data lake for, inter alia, advertising, location planning, attribution, competitor analysis and forward looking financial metrics; and 2) Location verification - utilising sophisticated machine learning and pattern recognition technologies Verify detects location ad-fraud and checks the accuracy and quality of location signals used to improve the performance of digital advertising.

 

The Company is a public limited company which is quoted on the AIM market of the London Stock Exchange and is incorporated and domiciled in the United Kingdom.

 

 

2 Basis of preparation

The financial information has been prepared in accordance with International Financial Reporting Standards ("IFRS") as adopted by the European Union, IFRIC interpretations and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS. The accounting policies adopted are consistent with those of the financial statements for the year ended 31 December 2019, as described in those financial statements.

 

The figures for the six-month periods ended 30 June 2020 and 30 June 2019 have not been audited. The figures for the year ended 31 December 2019 have been extracted from, but do not constitute, the consolidated financial statements of Location Sciences Group PLC for that year. Those financial statements have been delivered to the Registrar of Companies and included an unqualified auditors' report, with an emphasis of matter paragraph in relation to going concern and did not contain a statement under Section 498(2) or Section 498(3) Companies Act 2006.

 

 

3 Loss per share

 

Six months

ended

30 June 2020

Six months

ended

30 June

2019

Year ended

31 December 2019

 

Unaudited

Unaudited

Audited

Loss attributable to shareholders

(579,152)

(1,049,503)

(2,116,812)

 

 

 

 

 

No.

No.

No.

Weighted average number of shares (basic)

465,892,712

341,546,384

348,073,166

 

 

The calculation of basic loss per share of 0.12p (June 2019: 0.31p) is based on loss after taxation and the weighted average number of ordinary shares in issue during the period.

 

4 Segmental analysis

 

Operating segments are based on internal reports about components of the Company, which are regularly reviewed and used by the Board of Directors being the Chief Operating Decision Maker ("CODM") for strategic decision making and resource allocation, in order to allocate resources to the segment and to assess its performance.

 

During the first half of 2020 the Group has operated through its trading companies, Location Sciences AI Limited and Location Sciences (US), Inc. The business has two core solutions to its customers, namely: 1) Location data and insights - this is a SaaS where customers query Location Sciences' UK data lake for, inter alia, advertising, location planning, attribution, competitor analysis and forward looking financial metrics; and 2) Location verification - utilising sophisticated machine learning and pattern recognition technologies Verify detects location ad-fraud and checks the accuracy and quality of location signals used to improve the performance of digital advertising.

 

It should be noted that a segmental analysis of the Consolidated Statement of Financial Position is not part of routine management reporting and, consequently, no segmental analysis of assets is shown here. The US subsidiary is not yet trading at a materially significant level and thus geographical reporting is not reported.

 

 

 

An analysis of operating revenue is as follows:

 

Six months

ended

 

 

Six months

ended

 

 

 

Year ended

 

 

30 June

 

30 June

 

31 December

 

 

2020

Unaudited

£

 

2019

Unaudited

£

 

2019

Audited

£

 

Location data and insights

492,859

 

341,336

 

495,554

 

Verify

157,526

 

113,536

 

710,700

 

 

650,385

 

454,872

 

1,206,254

 

 

An analysis of EBITDA is as follows:

 

 

 

 

 

 

 

Six months

ended

 

Six months

ended

 

 

Year ended

 

 

30 June

 

30 June

 

31 December

 

 

2020

Unaudited

£

 

2019

Unaudited

£

 

2019

Audited

£

 

Location data and insights

(253,581)

 

(682,091)

 

(1,009,199)

 

Verify

(81,049)

 

(226,879)

 

(703,787)

 

 

(334,630)

 

(908,970)

 

(1,712,986)

An analysis of loss before tax is as follows:

 

 

 

Six months

ended

 

 

 

 

Six months

ended

 

 

 

 

 

Year ended

 

30 June

 

30 June

 

31 December

 

2020

Unaudited

£

 

2019

Unaudited

£

 

2019

Audited

£

Location data and insights

(430,741)

 

(856,483)

 

(1,345,445)

Verify

(208,411)

 

(285,494)

 

(938,275)

 

(639,152)

 

(1,141,977)

 

(2,283,720)

 

5 Share capital

 

 

 

 

 

 

30 June

 

30 June

 

31 December

 

2020

Unaudited

£

 

2019

Unaudited

£

 

2019

Audited

£

570,368,300 ordinary shares of 0.1p (June 2019 - 343,250,994 of 1p, December 2019 - 370,497,894 of

1p) each

 

 

570,369

 

 

 

3,432,511

 

 

 

3,704,979

1,040,712,398 deferred shares of 0.99p each (June 2019: 0.99p, December 2019: 0.99p

 

10,303,053

 

 

10,303,053

 

 

10,303,054

376,651,734 New Deferred shares of 0.9p (June 2019: nil, December 2019: nil)

 

3,389,866

 

 

-

 

 

-

 

14,263,288

 

13,735,564

 

14,008,033

       

 

Share issue

 

On 20 January 2020 6,153,840 ordinary shares of 1p each were issued at 1.25p per share to settle professional fees.

 

On 26 March 2020, the Company's share capital was reorganised to sub-divide the Existing Ordinary Shares to create two classes of shares: New Ordinary Shares with a nominal value of 0.1 pence and New Deferred Shares with a nominal value of 0.9 pence. The proportion of the issued ordinary share capital of the Company held by each Shareholder immediately before and after the Sub-division remained unchanged. The New Deferred Shares arising on completion of the Sub-division were in addition to the Existing Deferred Shares.

 

On 26 March 2020, 114,858,571 ordinary shares of 0.1p were issued at 0.875p pursuant to a placing, with a nominal value of £114,859 for aggregate consideration of £1,005,012 before costs. 3,428,571 shares were issued to settle professional fees in relation to the placing.

 

At the same time warrants were issued to those subscribing in the share placing, with every placee receiving two warrants for every three placing shares subscribed. Total warrants were issued giving the holders the right to subscribe for 74,057,995 ordinary shares. The warrants were exercisable at 0.1p during the period from admission of the placing shares until 30 June 2020, with any unexercised warrants lapsing following this date. They were exercised on the following dates:

 

15,457,332 exercised on 20 April 2020;

21,980,655 exercised on 06 May 2020;

1,524,000 exercised on 01 June 2020;

23,667,332 exercised on 16 June 2020; and

11,428,666 exercised on 30 June 2020.

 

On 6 May 2020 4,800,000 ordinary shares of 0.1p each were issued at 0.625p per share to settle professional fees in relation to the placing.

 

Share rights

 

Ordinary shares have attached to them full voting, dividend and capital distribution (including on winding up) rights; they do not confer any rights of redemption.

 

Deferred shares have attached to them no voting, dividend or capital distribution (including on winding up) rights; they do not confer any rights of redemption.

 

Warrants in Issue

 

Mike Staten holds 5,583,522 share warrants at an exercise price of 16.92 pence per share. For comparison the closing share price on 10 September 2020 was 0.51 pence per share. The fair value of the warrants is not material for adjustment.

 

 

6 Availability of half-year report

 

Copies of the half-year report are available on request from the Company's registered office at 20 Eastbourne Terrace, Paddington, London, W2 6LG and can also be viewed at:

 

https://www.locationsciencesgroup.ai/investor-relations/reports-presentations

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DZGMLMNGGGZM
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.